Blood tests for longevity: the optimal panel and how often to test
Discover which blood tests matter most for longevity. From PhenoAge biomarkers to emerging aging markers, build your optimal panel and testing schedule.
Your annual check-up bloodwork comes back “normal.” Your doctor says everything looks fine. But here’s what most standard panels miss: the difference between “not sick” and “optimally aging” is enormous — and it lives in biomarkers your doctor probably isn’t ordering.
Standard blood panels were designed to detect disease. Longevity blood panels are designed to detect aging — years before disease appears. The biomarkers that predict how fast you’re aging are often different from the ones that diagnose illness, and the optimal ranges for longevity are significantly tighter than conventional reference ranges.
A 2025 consensus of 60 international aging researchers identified 14 key biomarkers of aging — many of which are simple, inexpensive blood tests. Combined with wearable data and lifestyle metrics, these tests form the foundation of a personalized longevity strategy.
What you’ll learn:
- Which blood biomarkers predict biological aging (and which are overrated)
- The optimal longevity ranges vs. conventional “normal” ranges
- How to build your testing panel by age and risk profile
- How often to retest for meaningful trend tracking
Quick definition
Standard blood panels were designed to detect disease. Longevity blood panels are designed to detect aging — years before disease appears. The biomarkers that predict how fast you’re aging are often different from the ones that diagnose illness, and the optimal ranges for longevity are significantly tighter than conventional reference ranges.
Key takeaways
- Standard blood panels miss aging signals: Conventional “normal” ranges are too wide for longevity optimization — tighter optimal ranges reveal early aging
- The PhenoAge panel is your foundation: 9 inexpensive blood markers can calculate your biological age with validated accuracy
- Test annually from age 35: Establish baselines early and track trends over years, not single snapshots
- Trends reveal what snapshots hide: A marker moving in the wrong direction within “normal” range is a louder signal than a single outlier
Why standard blood panels aren’t enough
Quick definition: A longevity blood panel measures biomarkers associated with the rate of biological aging, not just the presence or absence of disease — giving you actionable data years before symptoms appear.
The “normal” range problem
Standard laboratory reference ranges are based on the 95th percentile of the general population — including people with undiagnosed chronic conditions, metabolic dysfunction, and subclinical inflammation. Being “within range” means you’re not an outlier compared to an often-unhealthy population.
For example:
- Fasting glucose: Standard range is 70–99 mg/dL (3.9–5.5 mmol/L). But research shows that fasting glucose above 85 mg/dL (4.7 mmol/L) is already associated with increased cardiovascular risk and accelerated glycation
- hs-CRP: Standard “normal” is below 3.0 mg/L. But for optimal aging, you want below 1.0 mg/L — a threefold difference
- HbA1c: Standard range allows up to 5.6%. Longevity-focused physicians target below 5.2%
What longevity panels add
A longevity-focused panel goes beyond “are you sick?” to answer “how fast are you aging?” It includes:
- PhenoAge biomarkers — the 9 blood markers used to calculate biological age
- Metabolic health markers — insulin sensitivity, glucose regulation, lipid profiles
- Inflammatory markers — chronic low-grade inflammation that drives aging
- Hormonal markers — age-sensitive hormones that decline predictably
- Micronutrient markers — deficiencies that accelerate specific aging pathways
The essential longevity biomarkers
Tier 1: PhenoAge panel (biological age calculation)
These 9 biomarkers form the basis of the PhenoAge biological age calculation — one of the most validated epigenetic clock proxies available through simple blood tests.
| Biomarker | Conventional range | Optimal longevity range | What it measures |
|---|---|---|---|
| Albumin | 3.5–5.5 g/dL | 4.3–5.0 g/dL | Liver function, nutritional status |
| Creatinine | 0.7–1.3 mg/dL | 0.8–1.1 mg/dL | Kidney function |
| Glucose (fasting) | 70–99 mg/dL | 72–85 mg/dL | Metabolic health |
| C-reactive protein (hs-CRP) | <3.0 mg/L | <1.0 mg/L | Systemic inflammation |
| White blood cell count | 4,500–11,000/μL | 4,500–7,000/μL | Immune activation |
| Lymphocyte % | 20–40% | 28–38% | Adaptive immunity |
| Mean cell volume (MCV) | 80–100 fL | 82–92 fL | Red blood cell size, B12/folate status |
| Red cell distribution width (RDW) | 11.5–14.5% | 11.5–13.0% | Red blood cell variation, inflammation |
| Alkaline phosphatase | 44–147 U/L | 45–85 U/L | Liver/bone health |
Notice how the optimal longevity ranges are dramatically tighter than conventional ranges. A “normal” fasting glucose of 98 mg/dL (5.4 mmol/L) is technically fine by standard criteria but well outside the optimal window for slow aging.
Tier 2: Metabolic and cardiovascular markers
These biomarkers assess the metabolic and cardiovascular systems most closely linked to lifespan.
| Biomarker | Optimal longevity range | Why it matters |
|---|---|---|
| Fasting insulin | 2–6 μIU/mL | Insulin resistance precedes diabetes by 10–15 years |
| HbA1c | 4.8–5.2% | 3-month glucose average; glycation driver |
| ApoB | <80 mg/dL | Best single predictor of cardiovascular risk |
| Lp(a) | <30 nmol/L | Genetic cardiovascular risk (test once) |
| Triglycerides/HDL ratio | <1.5 | Insulin resistance proxy |
| Homocysteine | <10 μmol/L | Methylation efficiency, cardiovascular and cognitive risk |
Tier 3: Hormonal markers
Hormones decline predictably with age, but the rate of decline varies enormously and is modifiable. For a comprehensive guide to understanding and optimizing each hormonal axis — testosterone, estrogen, thyroid, cortisol, and insulin — see our complete guide to hormonal health and longevity.
| Biomarker | Optimal longevity range | Why it matters |
|---|---|---|
| DHEA-S | Age-appropriate upper quartile | Adrenal reserve, correlates with all-cause mortality |
| Vitamin D (25-OH) | 40–60 ng/mL (100–150 nmol/L) | Immune function, bone health, inflammation |
| IGF-1 | 100–180 ng/mL | Growth signaling — too high or too low accelerates aging |
| Cortisol (morning) | 10–18 μg/dL | Stress axis regulation |
| Thyroid (TSH + Free T3/T4) | TSH 0.5–2.5 mIU/L | Metabolic regulation |
Tier 4: Micronutrient and organ-specific markers
| Biomarker | Optimal range | Why it matters |
|---|---|---|
| Vitamin B12 | 500–900 pg/mL | Neurological function, methylation |
| Ferritin | 40–100 ng/mL (men), 30–80 ng/mL (women) | Iron stores — both deficiency and excess are harmful |
| Magnesium (RBC) | 5.0–6.5 mg/dL | Enzyme cofactor for 300+ reactions |
| Omega-3 Index | 8–12% | Cardiovascular and brain health |
| GGT | <25 U/L | Liver health, oxidative stress |
| Urea/BUN | 7–18 mg/dL | Kidney function, protein metabolism |
The emerging biomarkers to watch
Longevity science is evolving rapidly. These biomarkers aren’t yet standard but are gaining clinical evidence.
GDF-15 (Growth Differentiation Factor 15)
Identified by the 2025 international expert consensus as one of the top aging biomarkers. GDF-15 rises with age and is associated with cardiovascular disease, frailty, and dysfunctional metabolism. Currently available through specialized labs.
Klotho
An anti-aging protein that supports kidney function, mineral balance, and brain health. Klotho levels decline with age, and higher levels consistently correlate with slower aging. Now available through some commercial longevity panels.
GlycanAge
Measures glycan modifications on IgG antibodies, reflecting chronic inflammation and immune aging. GlycanAge testing is becoming more accessible and provides a complementary view to PhenoAge.
CtBP2
A recently discovered blood molecule that tends to decline with age but remains elevated in people from long-lived families. Still primarily a research biomarker, but early evidence suggests it could become a longevity predictor.
How to build your panel by age
Not everyone needs every test. Here’s a practical framework for building your longevity panel based on age and health goals.
Ages 25–35: baseline establishment
Priority: Establish your personal baselines before age-related changes begin.
Recommended panel:
- Complete PhenoAge panel (9 biomarkers)
- Fasting insulin + HbA1c
- Lipid panel with ApoB
- Lp(a) — test once (genetically determined, doesn’t change)
- Vitamin D, B12, ferritin
- Thyroid (TSH)
Frequency: Every 2 years
Ages 35–50: active monitoring
Priority: Detect early metabolic drift and optimize modifiable markers.
Gender-specific checklists: For a complete, prioritized screening guide at 40+, see the health checklist for men over 40 or the health checklist for women over 40, which include cancer screenings, hormonal assessments, and functional fitness tests alongside blood work.
Recommended panel: Everything above, plus:
- Homocysteine
- DHEA-S
- Full thyroid panel (TSH, Free T3, Free T4)
- GGT + AST/ALT
- Omega-3 Index
- Magnesium (RBC)
- IGF-1
Frequency: Annually
Ages 50–65: comprehensive surveillance
Priority: Track hormonal decline, cardiovascular risk escalation, and organ function.
Recommended panel: Everything above, plus:
- Morning cortisol
- Testosterone (men) / estradiol (women)
- Coronary calcium score (imaging, not blood — every 3–5 years)
- Cystatin C (more sensitive kidney marker than creatinine)
- GDF-15 (if available)
Frequency: Every 6–12 months
Ages 65+: enhanced monitoring
Priority: Catch rapid changes early and maintain functional independence.
Recommended panel: Full comprehensive panel, plus:
- NLR (Neutrophil-to-Lymphocyte Ratio) — immune aging and inflammation
- Prealbumin — nutritional status in older adults
- CBC with differential — anemia screening
Frequency: Every 6 months
How often to test: the testing cadence
Testing too rarely misses trends. Testing too often wastes money and creates anxiety over normal fluctuations.
The optimal schedule
| Marker type | Frequency | Rationale |
|---|---|---|
| PhenoAge panel | Every 6–12 months | Captures biological age trajectory |
| Metabolic markers | Annually | Detects insulin resistance, glycation trends |
| Lipid panel | Annually | Cardiovascular risk monitoring |
| Hormones | Annually (every 6 months if supplementing) | Tracks age-related decline |
| Micronutrients | Annually | Identifies developing deficiencies |
| Lp(a) | Once in lifetime | Genetically fixed |
| Inflammatory markers | Every 6 months | Inflammaging is a key driver |
When to test more frequently
Increase testing to every 3–6 months if:
- You’ve made significant lifestyle changes and want to track results
- You’re on a supplement or hormone optimization protocol
- Your previous results showed a marker trending in the wrong direction
- You’re recovering from illness, injury, or a period of high stress
Practical tips for reliable results
- Always fast 12–14 hours before blood draws (water and black coffee are fine)
- Test in the morning (7–10 AM) when hormones and glucose are at their most consistent
- Avoid intense exercise for 48 hours before testing — it temporarily spikes inflammatory markers and liver enzymes
- Use the same lab for longitudinal comparison — different labs have different calibrations
- Request actual values, not just “normal/abnormal” flags
How to interpret your results for longevity
Step 1: Compare to longevity ranges, not standard ranges
If your doctor says your fasting glucose of 97 mg/dL (5.4 mmol/L) is “normal,” they’re correct by disease-detection standards. But for longevity optimization, you want below 85 mg/dL (4.7 mmol/L). The tables above give you the longevity-specific targets.
Step 2: Look for trends, not snapshots
A single blood test is a photograph. Two or more tests are a movie. The direction of change matters more than any single value:
- Albumin dropping from 4.8 to 4.3 g/dL over 2 years → investigate even though both values are “normal”
- hs-CRP rising from 0.5 to 1.8 mg/L → inflammatory process developing, even though 1.8 is “within range”
- HbA1c creeping from 5.0 to 5.4% → metabolic health declining, even though still below the prediabetes cutoff
Step 3: Identify clusters
Aging rarely shows up as a single abnormal marker. Look for patterns:
- Metabolic cluster: Rising glucose + rising HbA1c + rising triglycerides + rising fasting insulin = insulin resistance developing
- Inflammatory cluster: Rising hs-CRP + rising WBC + rising NLR = chronic low-grade inflammation
- Nutritional cluster: Falling albumin + falling B12 + rising MCV = malabsorption or dietary deficiency
- Hormonal cluster: Falling DHEA-S + rising cortisol + poor sleep metrics = HPA axis dysfunction
How SuperAge connects blood work to your biological age
Blood tests give you the biochemical picture. Wearable data gives you the functional picture. SuperAge bridges both.
PhenoAge integration
SuperAge uses the PhenoAge algorithm — built on the 9 blood biomarkers in Tier 1 above — to calculate your biological age from lab results. Enter your blood work and see exactly how your biochemistry maps to your rate of aging.
Wearable + blood work synergy
Your Apple Watch tracks HRV, resting heart rate, VO2 max, sleep, and activity continuously. SuperAge combines this real-time functional data with your periodic blood test results to give you a comprehensive biological age assessment — one that updates daily as wearable data flows in. For a practical guide to connecting all three data layers, see our article on building a personal health dashboard.
Track your interventions
Made a lifestyle change? Started a new exercise routine? Adjusted your diet? SuperAge tracks how these changes affect both your wearable metrics and your blood biomarkers over time, showing you what’s actually working to lower your biological age.
For hs-CRP specifically, a one-off high result should be handled with the repeat-test guide so your trend is not built on an acute spike.
If you are choosing a remote or at-home panel rather than a clinician-ordered draw, use this home biomarker test comparison checklist to screen lab quality, sample type, repeatability, and privacy before buying.
For an age-banded yearly plan, use the annual longevity blood test checklist.
Before the draw, follow a preparation plan for a longevity blood test so the results are easier to compare.
Frequently asked questions
How much does a longevity blood panel cost?
A basic PhenoAge panel (9 markers) typically costs $50–150 through direct-to-consumer labs. A comprehensive longevity panel with 30+ markers ranges from $200–500. Many markers are covered by insurance as part of an annual physical — ask your doctor to add specific tests to your standard order.
Can I order these tests without a doctor?
In most US states, yes. Direct-to-consumer lab services allow you to order blood tests independently. However, interpretation — especially of hormonal and micronutrient results — benefits from working with a physician familiar with longevity medicine, particularly an integrative or functional medicine practitioner.
What’s the single most important blood test for longevity?
If you could only add one test to your annual panel, make it hs-CRP (high-sensitivity C-reactive protein). Chronic low-grade inflammation is the single biggest driver of biological aging, and hs-CRP is inexpensive, widely available, and highly predictive of all-cause mortality. A result below 1.0 mg/L is optimal.
How do I lower my biological age based on blood tests?
Focus on the markers furthest from their optimal longevity ranges. The most commonly actionable improvements include: reducing fasting glucose through diet and exercise, lowering hs-CRP through anti-inflammatory nutrition and stress reduction, optimizing vitamin D through supplementation, and improving lipid markers through dietary changes. Before supplementing, see our evidence-based longevity supplement guide for ranked evidence by compound and guidance on testing first.
Are at-home blood test kits accurate?
Finger-prick kits (capillary blood) are reasonably accurate for some markers (HbA1c, lipids, vitamin D) but less reliable for others (full CBC, hormone panels). For longevity tracking, venipuncture (standard blood draw) provides the most consistent and comprehensive results. Use at-home kits for monitoring between full panels, not as replacements.
Key takeaways
- Standard blood panels miss aging signals: Conventional “normal” ranges are too wide for longevity optimization — tighter optimal ranges reveal early aging
- The PhenoAge panel is your foundation: 9 inexpensive blood markers can calculate your biological age with validated accuracy
- Test annually from age 35: Establish baselines early and track trends over years, not single snapshots
- Trends reveal what snapshots hide: A marker moving in the wrong direction within “normal” range is a louder signal than a single outlier
Take control of your longevity bloodwork today
Your blood tells the story of how fast you’re aging — if you know which chapters to read. Start with the PhenoAge panel, track your trends, and combine lab results with daily wearable data for the most complete picture of your biological age.
Ready to connect the dots? Download SuperAge (App Store) and see how your blood biomarkers and Apple Watch data combine to reveal your true biological age.
For a narrower decision guide, see Health markers to re-baseline at 60.
References
- Perri G, et al. An Expert Consensus Statement on Biomarkers of Aging for Use in Intervention Studies. The Journals of Gerontology: Series A. 2025. https://doi.org/10.1093/gerona/glae297
- Liu Z, et al. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV. PLOS Medicine. 2018. https://doi.org/10.1371/journal.pmed.1002718
- Klemera P, Doubal S. A new approach to the concept and computation of biological age. Mechanisms of Ageing and Development. 2006. https://pubmed.ncbi.nlm.nih.gov/16318865/
- Justice JN, et al. A framework for selection of blood-based biomarkers for geroscience-guided clinical trials. Geroscience. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6294998/
- Krištić J, et al. Glycans are a novel biomarker of chronological and biological ages. The Journals of Gerontology: Series A. 2014. https://pmc.ncbi.nlm.nih.gov/articles/PMC4049143/
- Sato M, et al. The secreted metabolite sensor CtBP2 links metabolism to healthy lifespan. Nature Aging. 2025. https://www.nature.com/articles/s43587-025-00973-4
Last updated: 2026-06-07. This article is regularly reviewed to ensure accuracy.